Gene-expression profiling in human cutaneous melanoma (Q35146553)

6 August 2017

1 reference

title

Gene-expression profiling in human cutaneous melanoma (English)

1 reference

6 August 2017

3

Jeffrey M Trent

1 reference

6 August 2017

Kristen M Carr

1

1 reference

PubMed ID

12789283

6 August 2017

Michael Bittner

series ordinal

2

1 reference

PubMed ID

12789283

6 August 2017

language of work or name

English

0 references

publication date

1 May 2003

1 reference

6 August 2017

1 reference

6 August 2017

22

1 reference

6 August 2017

20

1 reference

6 August 2017

3076-3080

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1206448

6 August 2017

0 references

cites work

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206448

Molecular classification of cutaneous malignant melanoma by gene expression profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206448

Genomic analysis of metastasis reveals an essential role for RhoC

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206448

Mutations of the BRAF gene in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206448

Use of a cDNA microarray to analyse gene expression patterns in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206448

Delineation of prognostic biomarkers in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206448

Chemosensitisation of malignant melanoma by BCL2 antisense therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206448

Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206448

Microphthalmia transcription factor. A sensitive and specific melanocyte marker for MelanomaDiagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206448

Expression profiling of medulloblastoma: PDGFRA and the RAS/MAPK pathway as therapeutic targets for metastatic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206448

Bcl2 regulation by the melanocyte master regulator Mitf modulates lineage survival and melanoma cell viability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206448

Molecular portraits of human breast tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206448

Computational analysis of microarray data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206448

DNA microarrays in clinical oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206448

Rho family proteins: coordinating cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206448

Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206448

The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206448

21 January 2018

RHO-GTPases and cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206448

Quantitative monitoring of gene expression patterns with a complementary DNA microarray

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206448

Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206448

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206448

Gene expression profiling predicts clinical outcome of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206448

Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206448

Activation of protein kinase D by signaling through the alpha subunit of the heterotrimeric G protein G(q).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206448

Expression profiling using cDNA microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206448

inferred from DOI database lookup

7 January 2021

based on heuristic

A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206448

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.ONC.1206448

1 reference

6 August 2017

1 reference

PubMed ID

12789283